Cat. # | Size | Qty. | Price |
---|---|---|---|
43065T | 1 Kit (6 x 20 microliters) |
|
$ 744 |
Product Includes | Quantity | Applications | Reactivity | MW(kDa) | Isotype |
---|---|---|---|---|---|
HIF-1α (E1V6A) Rabbit mAb 48085 | 20 µl |
|
H M | 120 | Rabbit IgG |
HIF-1β/ARNT (D28F3) XP® Rabbit mAb 5537 | 20 µl |
|
H M R Mk | 87 | Rabbit IgG |
VHL (E3X9K) Rabbit mAb 81292 | 20 µl |
|
H M | Rabbit IgG | |
p300 (D8Z4E) Rabbit mAb 86377 | 20 µl |
|
H Mk | 300 | Rabbit IgG |
SirT1 (1F3) Mouse mAb 8469 | 20 µl |
|
H M R Mk | 120 | Mouse IgG1 |
GSK-3β (D5C5Z) XP® Rabbit mAb 12456 | 20 µl |
|
H M R Mk | 46 | Rabbit IgG |
PKM2 (D78A4) XP® Rabbit mAb 4053 | 20 µl |
|
H M R Mk | 60 | Rabbit IgG |
LDHA (C4B5) Rabbit mAb 3582 | 20 µl |
|
H Mk | 37 | Rabbit IgG |
Glut1 (E4S6I) Rabbit mAb 73015 | 20 µl |
|
H M R Mk | 45-60 | Rabbit IgG |
Product Information
Monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Ala475 of human HIF-1α protein, Ile479 of human HIF-1β/ARNT protein, Ser406 of human PKM2 protein, near the carboxy terminus of human p300 protein and human Glut1 protein, and corresponding to the sequence of human LDHA protein.
Monoclonal antibodies are also produced by immunizing animals with recombinant proteins specific to human VHL protein, representing the central region of human SirT1 protein, and specific to the carboxy terminus of human GSK-3β protein.
Explore pathways + proteins related to this product.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.